tiprankstipranks
Trending News
More News >
Century Therapeutics (IPSC)
NASDAQ:IPSC
US Market

Century Therapeutics (IPSC) Income Statement

Compare
226 Followers

Century Therapeutics Income Statement

Last quarter (Q3 2025), Century Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Century Therapeutics's net income was $-34.42M. See Century Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.59M$ 2.23M$ 5.20M$ 0.00$ 0.00
Gross Profit
$ 6.59M$ 2.23M$ 5.20M$ -4.58M$ -1.75M
Operating Expenses
$ 144.73M$ 148.78M$ 139.03M$ 90.30M$ 47.42M
Depreciation and Amortization
$ 13.30M$ 13.04M$ 8.44M$ 4.58M$ 1.75M
EBITDA
$ -111.47M$ -121.21M$ -121.20M$ -89.92M$ -51.44M
Operating Income
$ -138.14M$ -146.55M$ -133.83M$ -94.88M$ -49.18M
Other Income/Expenses
$ 13.36M$ 11.75M$ 2.99M$ -898.00K$ -4.40M
Pretax Income
$ -124.78M$ -134.79M$ -130.84M$ -95.78M$ -53.58M
Net Income
$ -126.57M$ -136.67M$ -130.93M$ -95.82M$ -53.58M
Per Share Metrics
Basic EPS
$ -1.61$ -2.30$ -2.27$ -1.74$ -1.00
Diluted EPS
$ -1.61$ -2.30$ -2.27$ -1.74$ -1.00
Weighted Average Shares Outstanding
78.65M 59.31M 57.76M 55.01M 54.82M
Weighted Average Shares Outstanding (Diluted)
78.65M 59.31M 57.76M 55.01M 54.82M
Currency in USD

Century Therapeutics Earnings and Revenue History